Advances in idiopathic pulmonary fibrosis treatment, tracheobronchial reconstruction using bioengineering and clinical prediction rules for diagnosing pulmonary embolism

Lunchtime session
Chairs: G. O'Connor (Boston, United States of America), T. Maher (St. Albans (Hertfordshire), United Kingdom)
Aims: (i) To review the current treatments for idiopathic pulmonary fibrosis (IPF), with a particular focus on a novel treatment that was recently reported in the Journal of the American Medical Association (JAMA); (ii) to review the current approaches to tracheobronchial reconstruction in thoracic surgical oncology, with particular attention to a novel approach that was recently reported in JAMA; and (iii) to review the clinical prediction rules that are used to evaluate patients who present with symptoms or signs that are suggestive of pulmonary embolism, with a particular focus on the relevant randomised clinical trial evidence that was recently reported in JAMA.

Advances in tracheal and bronchial reconstruction using bioengineering approaches E. Martinod (Bobigny, France)
Advances in the clinical prediction rules that are used to assess patients with possible pulmonary embolism Y. Freund (Paris, France)